EDITORIALS

Our Invisible Patients

Sharon Manne

JCO Oct 20 2005: 7375–7377. First published on Sep 26 2005; 10.1200/JCO.2005.07.905. [Full Text] [PDF]

Improving the Care of Terminally Ill Cancer Patients and Their Families

Eduardo Bruera

JCO Oct 20 2005: 7378–7379. First published on Sep 26 2005; 10.1200/JCO.2005.07.910. [Full Text] [PDF]

Learning to Live With Missing Quality-of-Life Data in Advanced-Stage Disease Trials

Gary W. Donaldson and Carol M. Moinpour

JCO Oct 20 2005: 7380–7384. First published on Sep 26 2005; 10.1200/JCO.2005.07.022. [Full Text] [PDF]

Use of Positron Emission Tomography Scans in Ovarian Cancer: A Diagnostic Technique in Search of an Indication

Maurie Markman

JCO Oct 20 2005: 7385–7387. First published on Sep 26 2005; 10.1200/JCO.2005.07.007. [Full Text] [PDF]

Rebalancing Ratios and Improving Impressions: Later Thoughts From the Prostate Cancer Prevention Trial Investigators

James A. Talcott

JCO Oct 20 2005: 7388–7390. First published on Sep 26 2005; 10.1200/JCO.2005.07.909. [Full Text] [PDF]

Radiation-Induced Heart Disease: Vigilance Is Still Required

Robert G. Prosnitz and Lawrence B. Marks

JCO Oct 20 2005: 7391–7394. First published on Sep 26 2005; 10.1200/JCO.2005.07.011. [Full Text] [PDF]

Is There a Role for Routine p53 Testing in Colorectal Cancer?

Paulo M. Hoff

JCO Oct 20 2005: 7395–7396. First published on Sep 26 2005; 10.1200/JCO.2005.07.021. [Full Text] [PDF]

Cancer Vaccines: The Role of Tumor Burden in Tipping the Scale Toward Vaccine Efficacy

Lupe G. Salazar and Mary L. Disis

JCO Oct 20 2005: 7397–7398. First published on Sep 26 2005; 10.1200/JCO.2005.07.020. [Full Text] [PDF]

COMMENTS AND CONTROVERSIES

Comorbid Disease and Cancer: The Need for More Relevant Conceptual Models in Health Services Research

Jane M. Geraci, Carmen P. Escalante, Jean L. Freeman, and James S. Goodwin

JCO Oct 20 2005: 7399–7404. [Full Text] [PDF]

ORIGINAL REPORTS
Supportive Care and Quality of Life
	Posttraumatic Stress Symptoms During Treatment in Parents of Children With Cancer
	Anne E. Kazak, C. Alexandra Boeving, Melissa A. Alderfer, Wei-Ting Hwang, and Anne Reilly
	JCO Oct 20 2005: 7405–7410. First published on Sep 12 2005; 10.1200/JCO.2005.09.110. [Abstract] [Full Text] [PDF]
	Defining Cancer Patients As Being in the Terminal Phase: Who Receives a Formal Diagnosis, and What Are the Effects?
	B. Aabom, J. Kragstrup, H. Vondeling, L.S. Bakketeig, and H. Stovring
	JCO Oct 20 2005: 7411–7416. First published on Sep 12 2005; 10.1200/JCO.2005.16.493. [Abstract] [Full Text] [PDF]
	Assessment of Quality of Life in the Supportive Care Setting of the Big Lung Trial in Non–Small-Cell Lung Cancer
	J. Brown, H. Thorpe, V. Napp, D.J. Fairlamb, N.H. Gower, R. Milroy, M.K.B. Parmar, R.M. Rudd, S.G. Spiro, R.J. Stephens, D. Waller, P. West, and M.D. Peake
	JCO Oct 20 2005: 7417–7427. First published on Sep 12 2005; 10.1200/JCO.2005.09.158. [Abstract] [Full Text] [PDF]
	Quality of Life and Sexual Functioning in Cervical Cancer Survivors
	Michael Frumovitz, Charlotte C. Sun, Leslie R. Schover, Mark F. Munsell, Anuja Jhingran, J. Taylor Wharton, Patricia Eifel, Therese B. Bevers, Charles F. Levenback, David M. Gershenson, and Diane C. Bodurka
	JCO Oct 20 2005: 7428–7436. [Abstract] [Full Text] [PDF]
	Feasibility of Withholding Antibiotics in Selected Febrile Neutropenic Cancer Patients
	Claudi Oude Nijhuis, Willem A. Kamps, Simon M.G. Daenen, Jourik A. Gietema, Winette T.A. van der Graaf, Harrie J.M. Groen, Edo Vellenga, Els M. ten Vergert, Karin M. Vermeulen, Hillie G. de Vries-Hospers, and Eveline S.J.M. de Bont
	JCO Oct 20 2005: 7437–7444. [Abstract] [Full Text] [PDF]

Gynecologic Cancer
	Prediction of Response to Neoadjuvant Chemotherapy by Sequential F-18-Fluorodeoxyglucose Positron Emission Tomography in Patients With Advanced-Stage Ovarian Cancer
	Norbert Avril, Stefanie Sassen, Barbara Schmalfeldt, Joerg Naehrig, Stephan Rutke, Wolfgang A. Weber, Martin Werner, Henner Graeff, Markus Schwaiger, and Walther Kuhn
	JCO Oct 20 2005: 7445–7453. First published on Sep 12 2005; 10.1200/JCO.2005.06.965. [Abstract] [Full Text] [PDF]
	Utilization of Diagnostic Studies in the Pretreatment Evaluation of Invasive Cervical Cancer in the United States: Results of Intergroup Protocol ACRIN 6651/GOG 183
	Marco A. Amendola, Hedvig Hricak, Donald G. Mitchell, Bradley Snyder, Dennis S. Chi, Harry J. Long, III, James V. Fiorica, and Constantine Gatsonis
	JCO Oct 20 2005: 7454–7459. [Abstract] [Full Text] [PDF]

Prevention
	Assessing Benefit and Risk in the Prevention of Prostate Cancer: The Prostate Cancer Prevention Trial Revisited
	Eric A. Klein, Catherine M. Tangen, Phyllis J. Goodman, Scott M. Lippman, and Ian M. Thompson
	JCO Oct 20 2005: 7460–7466. First published on Sep 12 2005; 10.1200/JCO.2005.08.159. [Abstract] [Full Text] [PDF]
	Ionizing Radiation and Tobacco Use Increases the Risk of a Subsequent Lung Carcinoma in Women With Breast Cancer: Case-Only Design
	Michaela Prochazka, Per Hall, Giovanna Gagliardi, Fredrik Granath, Bo N. Nilsson, Peter G. Shields, Meredith Tennis, and Kamila Czene
	JCO Oct 20 2005: 7467–7474. [Abstract] [Full Text] [PDF]

Breast Cancer
	Cardiac Morbidity of Adjuvant Radiotherapy for Breast Cancer
	Debra A. Patt, James S. Goodwin, Yong-Fang Kuo, Jean L. Freeman, Dong D. Zhang, Thomas A. Buchholz, Gabriel N. Hortobagyi, and Sharon H. Giordano
	JCO Oct 20 2005: 7475–7482. First published on Sep 12 2005; 10.1200/JCO.2005.13.755. [Abstract] [Full Text] [PDF]
	Retrospective Analysis of Topoisomerase IIa Amplifications and Deletions As Predictive Markers in Primary Breast Cancer Patients Randomly Assigned to Cyclophosphamide, Methotrexate, and Fluorouracil or Cyclophosphamide, Epirubicin, and Fluorouracil: Danish Breast Cancer Cooperative Group
	Ann S. Knoop, Helle Knudsen, Eva Balslev, Birgitte B. Rasmussen, Jens Overgaard, Kirsten V. Nielsen, Andreas Schonau, Katrín Gunnarsdóttir, Karen E. Olsen, Henning Mouridsen, and Bent Ejlertsen
	JCO Oct 20 2005: 7483–7490. [Abstract] [Full Text] [PDF]
	Breast Cancer Risk Following Bilateral Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: An International Case-Control Study
	Andrea Eisen, Jan Lubinski, Jan Klijn, Pal Moller, Henry T. Lynch, Kenneth Offit, Barbara Weber, Tim Rebbeck, Susan L. Neuhausen, Parviz Ghadirian, William D. Foulkes, Ruth Gershoni-Baruch, Eitan Friedman, Gadi Rennert, Teresa Wagner, Claudine Isaacs, Charmaine Kim-Sing, Peter Ainsworth, Ping Sun, and Steven A. Narod
	JCO Oct 20 2005: 7491–7496. [Abstract] [Full Text] [PDF]
	Multifocal and Multicentric Breast Cancer: Does Each Focus Matter?
	Nathan J. Coombs and John Boyages
	JCO Oct 20 2005: 7497–7502. [Abstract] [Full Text] [PDF] [Publisher's Note]
	Immunohistochemical Expression of DNA Repair Proteins in Familial Breast Cancer Differentiate BRCA2-Associated Tumors
	Emiliano Honrado, Ana Osorio, José Palacios, Roger L. Milne, Lydia Sánchez, Orland Díez, Alicia Cazorla, Kirsi Syrjakoski, David Huntsman, Päivi Heikkilä, Enrique Lerma, Anne Kallioniemi, Carmen Rivas, William D. Foulkes, Heli Nevanlinna, and Javier Benítez
	JCO Oct 20 2005: 7503–7511. [Abstract] [Full Text] [PDF]
	Retrospective Analysis of Time to Recurrence in the ATAC Trial According to Hormone Receptor Status: An Hypothesis-Generating Study
	Mitch Dowsett, Jack Cuzick, Chris Wale, Tony Howell, Joan Houghton, and Michael Baum
	JCO Oct 20 2005: 7512–7517. [Abstract] [Full Text] [PDF]

Gastrointestinal Cancer
	The TP53 Colorectal Cancer International Collaborative Study on the Prognostic and Predictive Significance of p53 Mutation: Influence of Tumor Site, Type of Mutation, and Adjuvant Treatment
	Antonio Russo, Viviana Bazan, Barry Iacopetta, David Kerr, Thierry Soussi, Nicola Gebbia for the TP53-CRC Collaborative Study Group
	JCO Oct 20 2005: 7518–7528. First published on Sep 19 2005; 10.1200/JCO.2005.00.471. [Abstract] [Full Text] [PDF]
	Validation of a Postresection Pancreatic Adenocarcinoma Nomogram for Disease-Specific Survival
	Cristina R. Ferrone, Michael W. Kattan, James S. Tomlinson, Sarah P. Thayer, Murray F. Brennan, and Andrew L. Warshaw
	JCO Oct 20 2005: 7529–7535. [Abstract] [Full Text] [PDF]

Immunotherapy
	Clinical Trial Results of a HER2/neu (E75) Vaccine to Prevent Recurrence in High-Risk Breast Cancer Patients
	George E. Peoples, Jennifer M. Gurney, Matthew T. Hueman, Mike M. Woll, Gayle B. Ryan, Catherine E. Storrer, Christine Fisher, Craig D. Shriver, Constantin G. Ioannides, and Sathibalan Ponniah
	JCO Oct 20 2005: 7536–7545. First published on Sep 12 2005; 10.1200/JCO.2005.03.047. [Abstract] [Full Text] [PDF]

Genitourinary Cancer
	Prostate Size and Risk of High-Grade, Advanced Prostate Cancer and Biochemical Progression After Radical Prostatectomy: A Search Database Study
	Stephen J. Freedland, William B. Isaacs, Elizabeth A. Platz, Martha K. Terris, William J. Aronson, Christopher L. Amling, Joseph C. Presti, Jr, and Christopher J. Kane
	JCO Oct 20 2005: 7546–7554. [Abstract] [Full Text] [PDF]

Hematologic Malignancies
	Secondary Amenorrhea After Hodgkin’s Lymphoma Is Influenced by Age at Treatment, Stage of Disease, Chemotherapy Regimen, and the Use of Oral Contraceptives During Therapy: A Report From the German Hodgkin’s Lymphoma Study Group
	Karolin Behringer, Kai Breuer, Thorsten Reineke, Michael May, Lucia Nogova, Beate Klimm, Tatiana Schmitz, Ludwig Wildt, Volker Diehl, and Andreas Engert
	JCO Oct 20 2005: 7555–7564. [Abstract] [Full Text] [PDF]
	Tositumomab and Iodine-131 Tositumomab Produces Durable Complete Remissions in a Subset of Heavily Pretreated Patients With Low-Grade and Transformed Non-Hodgkin’s Lymphomas
	Richard I. Fisher, Mark S. Kaminski, Richard L. Wahl, Susan J. Knox, Andrew D. Zelenetz, Julie M. Vose, John P. Leonard, Stewart Kroll, Stanley J. Goldsmith, and Morton Coleman
	JCO Oct 20 2005: 7565–7573. First published on Sep 26 2005; 10.1200/JCO.2004.00.9217. [Abstract] [Full Text] [PDF]
	Prognostic Analysis for Survival in Adult Solid Organ Transplant Recipients With Post-Transplantation Lymphoproliferative Disorders
	Irene M. Ghobrial, Thomas M. Habermann, Matthew J. Maurer, Susan M. Geyer, Kay M. Ristow, Timothy S. Larson, Randall C. Walker, Stephen M. Ansell, William R. Macon, Gregory G. Gores, Mark D. Stegall, and Christopher G. McGregor
	JCO Oct 20 2005: 7574–7582. First published on Sep 26 2005; 10.1200/JCO.2005.01.0934. [Abstract] [Full Text] [PDF]
	Sustained Complete Molecular Remissions After Treatment With Imatinib-Mesylate in Patients With Failure After Allogeneic Stem Cell Transplantation for Chronic Myelogenous Leukemia: Results of a Prospective Phase II Open-Label Multicenter Study
	Georg Hess, Donald Bunjes, Wolfgang Siegert, Rainer Schwerdtfeger, Georg Ledderose, Barbara Wassmann, Guido Kobbe, Martin Bornhäuser, Andreas Hochhaus, Andrew J. Ullmann, Thomas Kindler, Ulrike Haus, Harald Gschaidmeier, Christoph Huber, and Thomas Fischer
	JCO Oct 20 2005: 7583–7593. [Abstract] [Full Text] [PDF]
	Prognostic Factors and Life Expectancy in Myelodysplastic Syndromes Classified According to WHO Criteria: A Basis for Clinical Decision Making
	Luca Malcovati, Matteo Giovanni Della Porta, Cristiana Pascutto, Rosangela Invernizzi, Marina Boni, Erica Travaglino, Francesco Passamonti, Luca Arcaini, Margherita Maffioli, Paolo Bernasconi, Mario Lazzarino, and Mario Cazzola
	JCO Oct 20 2005: 7594–7603. First published on Sep 26 2005; 10.1200/JCO.2005.01.7038. [Abstract] [Full Text] [PDF]
	Epstein-Barr Virus As a Marker of Survival After Hodgkin's Lymphoma: A Population-Based Study
	Theresa H.M. Keegan, Sally L. Glaser, Christina A. Clarke, Margaret L. Gulley, Fiona E. Craig, Joseph A. DiGiuseppe, Ronald F. Dorfman, Risa B. Mann, and Richard F. Ambinder
	JCO Oct 20 2005: 7604–7613. First published on Sep 26 2005; 10.1200/JCO.2005.02.6310. [Abstract] [Full Text] [PDF]
	Bleomycin Pulmonary Toxicity Has a Negative Impact on the Outcome of Patients With Hodgkin's Lymphoma
	William G. Martin, Kay M. Ristow, Thomas M. Habermann, Joseph P. Colgan, Thomas E. Witzig, and Stephen M. Ansell
	JCO Oct 20 2005: 7614–7620. First published on Sep 26 2005; 10.1200/JCO.2005.02.7243. [Abstract] [Full Text] [PDF]

Pediatric Cancer
	Multiagent Chemotherapy and Deferred Radiotherapy in Infants With Malignant Brain Tumors: A Report From the Children’s Cancer Group
	J. Russell Geyer, Richard Sposto, Mark Jennings, James M. Boyett, Richard A. Axtell, David Breiger, Emmett Broxson, Bernadine Donahue, Jonathan L. Finlay, Joel W. Goldwein, Linda A. Heier, Dennis Johnson, Claire Mazewski, Douglas C. Miller, Roger Packer, Diane Puccetti, Jerilynn Radcliffe, May Lin Tao, and Tania Shiminski-Maher
	JCO Oct 20 2005: 7621–7631. [Abstract] [Full Text] [PDF]
	Treatment With All-Trans Retinoic Acid and Anthracycline Monochemotherapy for Children With Acute Promyelocytic Leukemia: A Multicenter Study by the PETHEMA Group
	Juan J. Ortega, Luis Madero, Guillermo Martín, Amparo Verdeguer, Purificación García, Ricardo Parody, José Fuster, Antonio Molines, Andrés Novo, Guillermo Debén, Antonia Rodríguez, Eulogio Conde, Javier de la Serna, María J. Allegue, Francisco J. Capote, José D. González, Pascual Bolufer, Marcos González, and Miguel A. Sanz
	JCO Oct 20 2005: 7632–7640. [Abstract] [Full Text] [PDF]
	Rhabdoid Tumor of the Kidney in The National Wilms' Tumor Study: Age at Diagnosis As a Prognostic Factor
	Gail E. Tomlinson, Norman E. Breslow, Jeffrey Dome, Katherine Adams Guthrie, Pat Norkool, Sierra Li, Patrick R.M. Thomas, Elizabeth Perlman, J. Bruce Beckwith, Giulio J. D'Angio, and Daniel M. Green
	JCO Oct 20 2005: 7641–7645. [Abstract] [Full Text] [PDF]
	Phase I Study of O6-Benzylguanine and Temozolomide Administered Daily for 5 Days to Pediatric Patients With Solid Tumors
	Katherine E. Warren, Alberta A. Aikin, Madeleine Libucha, Brigitte C. Widemann, Elizabeth Fox, Roger J. Packer, and Frank M. Balis
	JCO Oct 20 2005: 7646–7653. [Abstract] [Full Text] [PDF]

Staging
	Improved Detection of Second Primary Cancer Using Integrated [18F] Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography for Initial Tumor Staging
	Joon Young Choi, Kyung Soo Lee, O. Jung Kwon, Young Mog Shim, Chung-Hwan Baek, Keunchil Park, Kyung-Han Lee, and Byung-Tae Kim
	JCO Oct 20 2005: 7654–7659. [Abstract] [Full Text] [PDF]

Melanoma
	Pegylated Arginine Deiminase Treatment of Patients With Metastatic Melanoma: Results From Phase I and II Studies
	Paolo A. Ascierto, Stefania Scala, Giuseppe Castello, Antonio Daponte, Ester Simeone, Alessandro Ottaiano, Gerardo Beneduce, Vincenzo De Rosa, Francesco Izzo, Maria Teresa Melucci, C. Mark Ensor, Archie W. Prestayko, Frederick W. Holtsberg, John S. Bomalaski, Mike A. Clark, Niramol Savaraj, Lynn G. Feun, and Theodore F. Logan
	JCO Oct 20 2005: 7660–7668. [Abstract] [Full Text] [PDF] [Publisher's Note]

Sarcomas
	Dermatofibrosarcoma Protuberans Treated at a Single Institution: A Surgical Disease With a High Cure Rate
	Marco Fiore, Rosalba Miceli, Chiara Mussi, Salvatore Lo Vullo, Luigi Mariani, Laura Lozza, Paola Collini, Patrizia Olmi, Paolo G. Casali, and Alessandro Gronchi
	JCO Oct 20 2005: 7669–7675. [Abstract] [Full Text] [PDF]

Bone Marrow Transplantation
	Early Allogeneic Stem-Cell Transplantation for Young Adults With Acute Myeloblastic Leukemia in First Complete Remission: An Intent-to-Treat Long-Term Analysis of the BGMT Experience
	Eric Jourdan, Jean-Michel Boiron, Nicole Dastugue, Norbert Vey, Gérald Marit, Françoise Rigal-Huguet, Lysiane Molina, Nathalie Fegueux, Arnaud Pigneux, Christian Recher, Jean-François Rossi, Michel Attal, Jean-Jacques Sotto, Dominique Maraninchi, Josy Reiffers, Valerie-Jeanne Bardou, Benjamin Esterni, and Didier Blaise
	JCO Oct 20 2005: 7676–7684. First published on Sep 26 2005; 10.1200/JCO.2005.02.5940. [Abstract] [Full Text] [PDF]

REVIEW ARTICLES
	Cardiotoxicity of Cancer Therapy
	Justin D. Floyd, Duc T. Nguyen, Raymond L. Lobins, Qaiser Bashir, Donald C. Doll, and Michael C. Perry
	JCO Oct 20 2005: 7685–7696. [Abstract] [Full Text] [PDF]
	Phase I to II Multicenter Study of Oblimersen Sodium, a Bcl-2 Antisense Oligonucleotide, in Patients With Advanced Chronic Lymphocytic Leukemia
	Susan M. O'Brien, Charles C. Cunningham, Anatoliy K. Golenkov, Anna G. Turkina, Steven C. Novick, and Kanti R. Rai
	JCO Oct 20 2005: 7697–7702. First published on Sep 26 2005; 10.1200/JCO.2005.02.4364. [Abstract] [Full Text] [PDF]

ASCO SPECIAL ARTICLE
	American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer
	Gary H. Lyman, Armando E. Giuliano, Mark R. Somerfield, Al B. Benson, III, Diane C. Bodurka, Harold J. Burstein, Alistair J. Cochran, Hiram S. Cody, III, Stephen B. Edge, Sharon Galper, James A. Hayman, Theodore Y. Kim, Cheryl L. Perkins, Donald A. Podoloff, Visa Haran Sivasubramaniam, Roderick R. Turner, Richard Wahl, Donald L. Weaver, Antonio C. Wolff, and Eric P. Winer
	JCO Oct 20 2005: 7703–7720. First published on Sep 12 2005; 10.1200/JCO.2005.08.001. [Abstract] [Full Text] [PDF] [Journal of Oncology Practice Summary]

BIOLOGY OF NEOPLASIA
	Biology of Progesterone Receptor Loss in Breast Cancer and Its Implications for Endocrine Therapy
	Xiaojiang Cui, Rachel Schiff, Grazia Arpino, C. Kent Osborne, and Adrian V. Lee
	JCO Oct 20 2005: 7721–7735. [Abstract] [Full Text] [PDF]

DIAGNOSIS IN ONCOLOGY

Modern Treatment of Lung Cancer: CASE 1. Amplification and Mutation of the Epidermal Growth Factor Receptor in Metastatic Lung Cancer With Remission From Gefitinib

Richard Schwab, Ferenc Pinter, Judit Moldavy, Judi Papay, Janos Strausz, Laszlo Kopper, Gyorgy Keri, Akos Pap, Istvan Petak, Karoly Oreskovich, and Laszlo Mangel

JCO Oct 20 2005: 7736–7738. [Full Text] [PDF]

Modern Treatment of Lung Cancer: CASE 2. Response to Erlotinib After Failure of Gefitinib in a Patient With Advanced Non–Small-Cell Lung Carcinoma

David H. Garfield

JCO Oct 20 2005: 7738–7740. [Full Text] [PDF]

Modern Treatment of Lung Cancer: CASE 3. Non-Metastatic Bilateral F-18 Fluorodeoxyglucose Avid Adrenal Glands in Non–Small-Cell Lung Cancer

Daniel B. Costa, J. Anthony Parker, and Susan T. Schumer

JCO Oct 20 2005: 7740–7742. [Full Text] [PDF]

CORRESPONDENCE

Is TGFBR1*6A Really Associated With Increased Risk of Cancer?

Hong-Tao Zhang, Jun Zhao, Shi-Ying Zheng, and Xiao-Feng Chen

JCO Oct 20 2005: 7743–7744. [Full Text] [PDF]

In Reply

Boris Pasche, Virginia Kaklamani, Alfred Rademaker, Nanjiang Hou, Habibul Ahsan, and Yu Chen

JCO Oct 20 2005: 7744–7746. [Full Text] [PDF]

Modulation of Epidermal Growth Factor Receptor–Positive Circulating Tumor Cells by Chemotherapy in Non–Small-Cell Lung Cancer Patients

Nicola Normanno, Antonella De Luca, Monica R. Maiello, and Cesare Gridelli

JCO Oct 20 2005: 7746–7748. [Full Text] [PDF]

Mafosfamide: A New Intra-CSF Chemotherapy?

Marc C. Chamberlain

JCO Oct 20 2005: 7748–7749. [Full Text] [PDF]

In Reply

Tommaso De Pas, Filippo de Braud, Lorenzo Spaggiari, and Giuseppe Pelosi

JCO Oct 20 2005: 7748. [Full Text]

In Reply

Susan M. Blaney, Stacey L. Berg, Frank Balis, and David Poplack

JCO Oct 20 2005: 7749. [Full Text] [PDF]

Systematic Review of the Diagnosis and Management of Malignant Extradural Spine Cord Compression: The Cancer Care Ontario Practice Guidelines Initiative's Neuro-Oncology Disease Site Group

Marc C. Chamberlain, Andrew Sloan, and Frank Vrionis

JCO Oct 20 2005: 7750–7751. [Full Text] [PDF]

In Reply

D. Andrew Loblaw, Normand J. Laperriere, and James Perry

JCO Oct 20 2005: 7751–7752. [Full Text] [PDF]

In Reply

Gretchen G. Kimmick, Bercedis L. Peterson, Alice B. Kornblith, Jeanne Mandelblatt, Jeffrey L. Johnson, Judith Wheeler, Robin Heinze, Harvey J. Cohen, and Hyman B. Muss

JCO Oct 20 2005: 7752–7753. [Full Text] [PDF]

Central Role of the Research Nurse in Improving Accrual of Older Persons to Cancer Treatment Trials

Irene Best

JCO Oct 20 2005: 7752. [Full Text]

Gallbladder Cancer, a Different Disease that Needs Individual Trials

Jorge Gallardo, Betzabé Rubio, Luis Villanueva, and Olga Barajas

JCO Oct 20 2005: 7753–7754. [Full Text] [PDF]

In Reply

Jennifer J. Knox

JCO Oct 20 2005: 7754–7755. [Full Text] [PDF]

Medicinal Cannabis in Oncology Practice: Still a Bridge Too Far?

Willem K. Scholten

JCO Oct 20 2005: 7755–7756. [Full Text] [PDF]

In Reply

Floris A. de Jong, Frederike K. Engels, Ron H.J. Mathijssen, Lia van Zuylen, Jaap Verweij, Remco P.H. Peters, and Alex Sparreboom

JCO Oct 20 2005: 7756. [Full Text] [PDF]

Is Restoring Platinum Sensitivity the Best Goal for Cetuximab in Recurrent/Metastatic Nasopharyngeal Cancer?

Lisa Licitra, Paolo Bossi, Laura D. Locati, and Cristiana Bergamini

JCO Oct 20 2005: 7757–7758. [Full Text] [PDF]

In Reply

Brigette B.Y. Ma and Anthony T.C. Chan

JCO Oct 20 2005: 7758–7759. [Full Text] [PDF]

Neoadjuvant Therapy With Trastuzumab, Paclitaxel and Epirubicin for HER-2–Positive Operable Breast Cancer

Manmeet S. Ahluwalia and Hamed A. Daw

JCO Oct 20 2005: 7759–7760. [Full Text] [PDF]

In Reply

Aman U. Buzdar, Richard L. Theriault, Kelly K. Hunt, and Gabriel N. Hortobagyi

JCO Oct 20 2005: 7760–7761. [Full Text] [PDF]

Ewing's Sarcoma of the Rectum: Can We Afford Not to Use Molecular Pathology?

Jean-Yves Pierga and Jorge S. Reis-Filho

JCO Oct 20 2005: 7761–7762. [Full Text] [PDF]

In Reply

J. Vardy, S.J. Clarke, P.M. Yarrow, and B.P.C. Lin

JCO Oct 20 2005: 7762. [Full Text]

ERRATUM

ERRATUM

JCO Oct 20 2005: 7763. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.